...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Trial
1
Dec 10, 2019 03:57PM
1
Dec 10, 2019 09:20PM
3
Feb 09, 2020 10:02AM

My guess is this one:

American Association for Cancer Research 2020 meeting in San Diego end of April. https://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=213

5
Feb 13, 2020 02:57PM
Share
New Message
Please login to post a reply